Search PDMR transactions

Notifier
Name of person with notification obligation
Lars Öhman
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Lars Öhman
Position
Chairman of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Lipigon Pharmaceuticals AB
Issuer´s LEI code
549300XPO40YR12SLY87
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA Lipigon Pharmaceuticals BTA SE0017911613 Acquisition 96,000 Quantity 2.15 SEK 16/06/2022 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Lipigon Pharmaceuticals BTA SE0017911613 Acquisition 16/06/2022 Outside a trading venue 96,000 (Quantity) 2.15 SEK
Total: 96,000
<< Back